Targeting of inflammatory signaling pathways in macrophages via deletion of JNK, IKKβ, or Toll-like receptor (TLR) 4 is sufficient to reduce hepatic steatosis and inflammation (47–49). This evidence concerns the gene MAPK8 and fatty liver disease.